Navigation Links
OrbusNeich Granted Expanded U.S. Patent of Genous™ Endothelial Progenitor Cell Capture Technology
Date:1/4/2011

FT. LAUDERDALE, Fla., Jan. 4, 2011 /PRNewswire/ -- OrbusNeich today announced that the United States Patent and Trademark Office (USPTO) has granted an additional patent expanding protection of the company's Genous endothelial progenitor cell (EPC) capture technology.

The patent (U.S. Pat. No. US 7,803,183) covers a coating on an implantable medical device that has one or more layers of a matrix.  Incorporated into the matrix are antibodies or antibody fragments that allow for capture in vivo of circulating EPCs.

"This patent further expands OrbusNeich's unique intellectual property portfolio of the Genous technology," said Robert Cottone, vice president of intellectual property and technologies at OrbusNeich. "We are continuing to develop our pro-healing technology for our next generation stent platform, which combines both luminal cell capture with abluminal drug elution and is currently in clinical trial evaluation."

About Genous  

Genous is OrbusNeich's patented EPC capture technology that promotes the accelerated natural healing of the vessel wall after the implantation of blood-contact devices such as stents. The technology consists of an antibody surface coating that attracts EPCs circulating in the blood to the device to form an endothelial layer that provides protection against thrombosis and modulates restenosis.

The Genous Stent, which  has been commercially available in more than 60 countries since 2005, has been proven as a safe, effective alternative to drug-eluting stents and is supported by data from more than 5,000 patients in company-sponsored clinical studies. There is a growing body of evidence from multiple clinical studies that the Genous Stent is effective for patients who are non-responsive to or cannot tolerate long-term dual antiplatelet therapy.

About OrbusNeich

OrbusNeich is a global company that designs, develops, manufactures and markets innov
'/>"/>

SOURCE OrbusNeich
Copyright©2010 PR Newswire.
All rights reserved

Page: 1 2

Related medicine technology :

1. OrbusNeichs Genous™ Stent Shows Favorable Outcomes for Treatment of Coronary Artery Bifurcation Lesions Compared to Bare Metal Stents
2. Randomized Clinical Trial of OrbusNeichs Genous™ Bio-engineered R stent™ in China Completes Patient Enrollment
3. Data from Multiple Clinical Trials of OrbusNeichs Genous™ Bio-engineered R Stent™ Demonstrate Safety and Effectiveness Across Challenging Patient Subsets as Presented at TCT 2010
4. Patient Enrollment Completed in First Randomized Clinical Study of OrbusNeichs Combo™ Bio-engineered Sirolimus Eluting Stent
5. OrbusNeichs Genous™ Bio-engineered R stent™ Shows Favorable Safety Profile and Clinical Outcomes in Combination with Paclitaxel-Coated Balloon for De Novo Coronary Artery Disease
6. 100 Percent Coverage of Struts and Complete Neointimal Coverage of OrbusNeichs Genous™ Bio-engineered R stent™ Demonstrated 26 Days Post-Implantation in STEMI Patient
7. Data Show OrbusNeichs Genous™ Bio-engineered R stent™ is Safe and Effective in Combination with Drug-Eluting Balloon
8. OrbusNeichs Genous(TM) Bio-engineered R stent(TM) Demonstrates Excellent Safety and Clinical Outcomes in High-Risk Elderly Patients
9. Data Presented at ACC/i2 Summit Demonstrate Impressive Long Term Clinical Outcomes in Real World Patients Treated with OrbusNeichs Genous(TM) Bio-engineered R stent(TM)
10. OrbusNeich Announces First Patient Enrolled in Randomized Clinical Trial of Genous(TM) Bio-engineered R stent(TM) in China
11. Clinical Data Presented at Asia PCR/Sing LIVE Demonstrate Benefits of OrbusNeichs Genous(TM) Bio-engineered R stent(TM) in Challenging Patient Subsets
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:7/22/2014)... NASHVILLE, Tenn. , July 22, 2014 ... will release second quarter 2014 financial results after the ... call and live Internet webcast will be held on ... to discuss the results. To participate in ... 253-237-1032 (for international callers).  A rebroadcast of the teleconference ...
(Date:7/22/2014)... 22, 2014  Decision Resources Group finds that the market ... will remain relatively stagnant at a value of around ... percutaneous coronary intervention (PCI) volumes are growing faster in ... as the United States and ... by the increase in penetration of PCI procedures relative to ...
(Date:7/22/2014)... Research and Markets  has announced the ... report to their offering. ... diagnose, monitor, and assess medical conditions, diseases, or infections ... for earlier and more targeted treatment. These tests are ... results. This kind of diagnostics provides early detection of ...
Breaking Medicine Technology:Cumberland Pharmaceuticals To Announce Second Quarter 2014 Financial Results On August 5, 2014 2The Canadian Interventional Cardiology Device Market Will Remain Relatively Stagnant Through 2022 at Around $80 Million 2The Canadian Interventional Cardiology Device Market Will Remain Relatively Stagnant Through 2022 at Around $80 Million 3Global IVD Market 2014-2018: Key Vendors are Abbott Laboratories, Johnson & Johnson, Roche Diagnostics and Siemens Healthcare 2Global IVD Market 2014-2018: Key Vendors are Abbott Laboratories, Johnson & Johnson, Roche Diagnostics and Siemens Healthcare 3
... CALGARY, Alberta, July 13, 2011 Fero Industries, ... report that Merck S.A. de C.V. has successfully ... points-of-sale to over 2,500 outlets and pharmacy chains. ... well-known retailers including WalMart Supercenters, Superama, Farmacias del ...
... Schein, Inc. (NASDAQ: HSIC ), the largest provider ... the Henry Schein Cares Foundation, Inc., announced today a contribution ... help provide health care to those who have been affected ... earthquake in New Zealand, and tornadoes in the United States. ...
Cached Medicine Technology:Fero Industries Expands Sucanon® Distribution in Mexico 2Fero Industries Expands Sucanon® Distribution in Mexico 3Henry Schein Cares Foundation and Henry Schein Cares Contribute More Than $375,000 in Financial and Product Donations for Disaster Relief Efforts on Three Continents 2Henry Schein Cares Foundation and Henry Schein Cares Contribute More Than $375,000 in Financial and Product Donations for Disaster Relief Efforts on Three Continents 3
(Date:7/22/2014)... (WASHINGTON, July 22, 2014) The American Society ... of the University of California Los Angeles with ... research in iron homeostasis, including the discovery of the ... iron metabolism. This award, named after the Nobel Prize ... recognizes pioneering research achievements in hematology that have represented ...
(Date:7/22/2014)... you eat pretty much everything you put on your ... study shows that the average adult eats 92% of whatever ... "If you put it on your plate, it,s going ... forthcoming book, Slim by Design, Professor of Marketing and Director ... co-author Katherine Abowd Johnson analyzed 1179 diners and concluded that ...
(Date:7/22/2014)... American Society of Hematology (ASH) will present the Society,s ... Lifetime Achievement in Hematology, to Kanti R. Rai, MD, ... of Medicine for his 50-year career combining landmark clinical ... exceptional patient care. , The Wallace H. Coulter ... an individual who has been a vital contributor to ...
(Date:7/22/2014)... 22, 2014 SIMpalm, a ... payment app for Forte Payment System. Forte Mobile Payment ... payments on iPhone, iPod and iPad. The app ... recently updated by SIMpalm. This update was for iOS ... supported on iOS 4.3 and is available to download ...
(Date:7/22/2014)... 6th Latin American Conference on Lung Cancer (LALCA 2014) ... Lima, Peru. , Lung Cancer is still the leading ... worldwide. Building on the success of the previous conferences ... speakers will discuss the science and advances in the ... worldwide and Latin America in particular. , With tobacco ...
Breaking Medicine News(10 mins):Health News:Tomas Ganz, M.D., Ph.D., to present 2014 ASH E. Donnall Thomas Lecture 2Health News:Tomas Ganz, M.D., Ph.D., to present 2014 ASH E. Donnall Thomas Lecture 3Health News:ASH honors Kanti R. Rai, M.D., with Coulter Award for Lifetime Achievement 2Health News:ASH honors Kanti R. Rai, M.D., with Coulter Award for Lifetime Achievement 3Health News:ASH honors Kanti R. Rai, M.D., with Coulter Award for Lifetime Achievement 4Health News:SIMpalm Launched Updated Forte Mobile Payment App on iPhone and iPad for Its Client 2Health News:SIMpalm Launched Updated Forte Mobile Payment App on iPhone and iPad for Its Client 3
... By Jenifer Goodwin HealthDay Reporter , MONDAY, Aug. ... Go for a walk after dinner. Play tag with your kids ... of exercise -- about 150 minutes, or 2.5 hours, of moderate ... by about 14 percent. Those who did more -- about ...
... -- Suicide is the 11th leading cause of death in ... taking their own lives. Sadly, each year tens of thousands ... family and friends, some warning signs exist. Often a simple ... a person toward help and treatment. A new ...
... While deformities of the lesser toes (all toes other than ... surgical and nonsurgical treatments for these conditions that are usually ... of the American Academy of Orthopaedic Surgeons (JAAOS) shows ... be symptoms of other conditions, early assessment and treatment by ...
... elderly people in the US, registered with Medicare, do not ... according to Dr. Larissa Nekhlyudov and colleagues from Harvard Medical ... and the National Cancer Institute, shows that cost-related medication non-adherence ... not filling in a prescription because it is too expensive ...
... CORAL GABLES, FL (August 1, 2011) Researchers from the ... Germany have developed a mathematical model to understand and predict ... metastasis, in hopes of creating highly personalized treatment strategies for ... new online journal Scientific Reports . When a ...
... 2011 Annual Meeting & OTO EXPO of the American ... (AAO-HNSF), the largest meeting of ear, nose, and throat ... in San Francisco, CA. Featuring more than 386 ... course hours for attendees, the annual meeting is a ...
Cached Medicine News:Health News:Even a Little Exercise Helps the Heart, Study Finds 2Health News:Even a Little Exercise Helps the Heart, Study Finds 3Health News:Mayo Clinic: Primary physicians may hold key to suicide prevention 2Health News:Don't suffer in silence with toe pain 2Health News:Barrier to effective treatment for seniors -- the cost of medicine 2Health News:Using math to fight cancer 2Health News:World's largest meeting of ear, nose and throat doctors 2
Y shape rotator tip. Shaft angled 7 mm from tip to bend. Round knurled handle with polished finish. Most popular size or model....
1.0 mm long 90 degree angled tip with black ebonized shaft. Titanium handle with position reference indicator. Shaft length 52 mm, handle length 100 mm....
Delicate pick with 90 degree hook tip. 20 gauge shaft with balanced titanium handle. Dark finish for reduced glare....
0.5 mm angled tip. Round knurled handle with dull finish. Tip angle: 110 degrees. Most popular size or model....
Medicine Products: